| Preferred Name |
golimumab |
| Synonyms |
CNTO-148 |
| ID |
http://purl.bioontology.org/ontology/MESH/C529000 |
| altLabel |
CNTO-148 CNTO 148 Simponi |
| cui |
C2353893 C2987601 C2684024 |
| HM |
D000911 |
| Inverse of RB |
91X1KLU43E 0 |
| isa |
http://purl.bioontology.org/ontology/MESH/D000893 |
| LT |
TRD |
| Mapped to | |
| MDA |
20080520 |
| MeSH Frequency |
779 |
| MMR |
20201221 |
| notation |
C529000 |
| PA |
D000893 D007166 D000079424 |
| prefLabel |
golimumab |
| SC |
1 |
| Scope Statement |
Golimumab plus MTX effectively reduces the signs and symptoms of RA and is generally well tolerated in patients with an inadequate response to MTX. |
| SRC |
Arthritis Rheum. 2008 Apr;58(4):964-75 |
| TERMUI |
T720101 T754770 T000966337 T000966338 |
| TH |
NLM (2008) US FDA SRS (2017) INN (19XX) NLM (2020) |
| tui |
T109 T116 T129 T121 |